Metabolic dysfunction-associated fatty liver disease in the elderly with diabetic foot ulcers: A longitudinal cohort study

被引:0
|
作者
Zhang, Liya [1 ]
Lin, Yuanmei [2 ]
Huang, Xiuxian [2 ]
Zhai, Zhenwei [2 ]
Wei, Rongyan [2 ]
Mo, Jiacheng [3 ,4 ]
Li, Junjun [5 ,6 ]
Lu, Wensheng [2 ,7 ]
机构
[1] Shanxi Yingkang Healthcare Gen Hosp, Dept Endocrinol, Yuncheng, Peoples R China
[2] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Endocrinol & Metab, Nanning, Peoples R China
[3] Guangxi Acad Med Sci, Informat Network Ctr, Nanning, Peoples R China
[4] Peoples Hosp Guangxi Zhuang Autonomous Reg, Nanning, Peoples R China
[5] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Deans Off, Nanning, Peoples R China
[6] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Deans Off, Nanning 530021, Guangxi, Peoples R China
[7] Guangxi Acad Med Sci, Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Endocrinol & Metab, Nanning 530021, Guangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
diabetic foot ulcers; metabolic dysfunction-associated fatty liver disease; ulcer recurrence; CLASSIFICATION; COMPLICATIONS;
D O I
10.1111/iwj.14586
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
This study aimed to explore the association between metabolic-associated fatty liver disease (MAFLD) and ulcer recurrence risk in patients with diabetic foot ulcers (DFUs) through an ambispective longitudinal cohort. From December 2013 to December 2022, a total of 482 inpatients with DFUs (PEDIS grade 3 and above with a severe infection) were eligible for inclusion in this study. This was an ambispective longitudinal cohort study. All participants were followed up every 6 months for 9 years with a median of 36 months. According to whether having MAFLD or not, all subjects were placed into two groups: non-MAFLD (n = 351) and MAFLD (n = 131). The association between MAFLD and ulcer recurrence in patients with DFUs was then evaluated through multivariate Cox regression analysis, stratified analyses and Kaplan-Meier survival analysis. Throughout the follow-up period, out of 482 subjects with DFUs, 68 had ulcer recurrence (14.1%). Three Cox regression models were established for data analyses. In the model I (unadjusted), MAFLD was significantly associated with the ulcer recurrence rate in patients with DFUs (HR = 1.79; 95% CI = 1.097-2.92; p = 0.02). Model II (adjusted model I with gender and age) (HR = 1.781; 95% CI = 1.09-2.912; p = 0.021) and model III (adjusted model II with CVD, duration of diabetes and Cr.) (HR = 1.743; 95% CI = 1.065-2.855; p = 0.027) also showed that MAFLD was significantly related to the ulcer recurrence risk in patients with DFUs, respectively. Stratified analysis indicated that subjects aged >= 60 had a greater risk of ulcer recurrence in MAFLD than in non-MAFLD (HR = 2.31; 95% CI = 1.268-4.206; p = 0.006). Kaplan-Meier survival curve analysis showed that ulcer recurrence rate had a significant association with MAFLD (log-rank, p = 0.018). This study indicated a close association between ulcer recurrence risk and MAFLD in patients with DFUs, especially in the elderly (aged >= 60). Therefore, special attention should be paid to the elderly with both DFUs and MAFLD because they have a higher ulcer recurrence rate than other general populations in routine clinical practice.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and MACCEs in Patients with Diabetic Foot Ulcers: An Ambispective Longitudinal Cohort Study
    Huang, Xiuxian
    Li, Zhengming
    Zhai, Zhenwei
    Wang, Qiu
    Wei, Rongyan
    Mo, Jiacheng
    Huang, Jianhao
    Lu, Wensheng
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 1119 - 1130
  • [2] The Role of Metabolic Dysfunction-Associated Fatty Liver Disease in Developing Chronic Kidney Disease: Longitudinal Cohort Study
    Wei, Suosu
    Song, Jian
    Xie, Yujie
    Huang, Junzhang
    Yang, Jianrong
    JMIR PUBLIC HEALTH AND SURVEILLANCE, 2023, 9
  • [3] Impact of alcohol consumption on metabolic dysfunction-associated fatty liver disease development and remission: A longitudinal cohort study
    Sogabe, Masahiro
    Okahisa, Toshiya
    Kagawa, Miwako
    Kashihara, Takanori
    Fujmoto, Shota
    Kawaguchi, Tomoyuki
    Yokoyama, Reiko
    Kagemoto, Kaizo
    Tanaka, Hironori
    Kida, Yoshifumi
    Tomonari, Tetsu
    Kawano, Yutaka
    Sato, Yasushi
    Nakasono, Masahiko
    Takayama, Tetsuji
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2024, 54 (09)
  • [4] Association of metabolic dysfunction-associated fatty liver disease with gallstone development: A longitudinal study
    Sogabe, Masahiro
    Okahisa, Toshiya
    Kagawa, Miwako
    Sei, Motoko
    Kagemoto, Kaizo
    Tanaka, Hironori
    Kida, Yoshifumi
    Nakamura, Fumika
    Tomonari, Tetsu
    Okamoto, Koichi
    Miyamoto, Hiroshi
    Sato, Yasushi
    Nakasono, Masahiko
    Takayama, Tetsuji
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 (04) : 754 - 761
  • [5] Extrahepatic malignancies in metabolic dysfunction-associated fatty liver disease: A nationwide cohort study
    Park, Min Kyung
    Hur, Moon Haeng
    Moon, Hye-Sung
    Shin, Hyunjae
    Chung, Sung Won
    Won, Sungho
    Lee, Yun Bin
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Yoon, Jung-Hwan
    Kim, Yoon Jun
    LIVER INTERNATIONAL, 2024, 44 (03) : 799 - 810
  • [6] Association of metabolic dysfunction-associated fatty liver disease with white matter hyperintensity and cognitive decline: A longitudinal cohort study
    Jung, Inha
    Park, So Young
    Lee, Da Young
    Cho, Hyun Joo
    Lee, Seung Ku
    Seo, Ji A.
    Kim, Nan Hee
    Shin, Chol
    Yu, Ji Hee
    DIABETES OBESITY & METABOLISM, 2025, 27 (04): : 2271 - 2279
  • [7] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [8] Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
    Lee, Hokyou
    Lee, Yong-ho
    Kim, Seung Up
    Kim, Hyeon Chang
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (10) : 2138 - +
  • [9] Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
    Kim, Kyung-Soo
    Hong, Sangmo
    Ahn, Hong-Yup
    Park, Cheol-Young
    DIABETES & METABOLISM JOURNAL, 2023, 47 (02) : 220 - 231
  • [10] Diabetes and metabolic dysfunction-associated fatty liver disease
    Davis, Timothy M. E.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 123